(Q53736384)

English

The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites. (English)

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

L Hary

1

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

M Andrejak

2

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

S Leleu

3

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

J Orfila

4

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

J P Capron

5

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

publication date

1 January 1989

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

36

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

6

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

613-616

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

https://scigraph.springernature.com/pub.10.1007/bf00637745

0 references

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-associated changes in ceftriaxone pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftriaxone A Review of its Antibacterial Activity, Pharmacological Properties and Therapeutic Use

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous bacterial peritonitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary Bacterial Peritonitis in Cirrhotic Patients With Ascites

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftriaxone: renal and biliary excretion and effect on the colon microflora

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Septicaemia and spontaneous peritonitis in the cirrhotic (author's transl)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Analysis of serum cefotaxime and desacetylcefotaxime by high performance liquid ion exchange chromatography]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cefotaxime A review of its Antibacterial Activity, Pharmacological Properties and Therapeutic Use

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of ceftazidime and ceftriaxone and their penetration into the ascitic fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose ceftriaxone kinetics in liver insufficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/2776819

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00637745

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

1 reference

Europe PubMed Central

18 May 2018

http://europepmc.org/abstract/MED/2776819

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53736384&oldid=2143589977"